Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Tags:
Sanofi, FDA, clinical trials, hemophilia A, efanesoctocog alfa, Roche, Hemlibra
Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education
Endpoints
Wed, 01/25/23 - 10:51 pm
Tags:
Sanofi, social media, TikTok, Instagram, RSV, pharma marketing
Sanofi promises money back for discontinued blood disorder treatment – in some cases
Endpoints
Mon, 01/23/23 - 10:00 pm
Tags:
Sanofi, drug warranty programs, Cablivi, aTTP
Sanofi and CytoReason target IBD in expanded collaboration
Pharma Live
Mon, 01/23/23 - 11:03 am
Tags:
Sanofi, CytoReason, IBD, R&D
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
BioPharma Dive
Wed, 01/11/23 - 11:08 pm
Tags:
JPMHC 2023, Takeda, Bristol Myers Squibb, Prime Medicine, Sanofi
Sanofi extends commitment to $750M biotech startup fund
Endpoints
Wed, 01/11/23 - 10:55 pm
Tags:
Sanofi, Sanofi Ventures, funding
JPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO says
Fierce Pharma
Wed, 01/11/23 - 10:54 am
Tags:
JPMHC 2023, Sanofi, Paul Hudson, Pharma CEOs, Dupixent
JPM Day 2: Highlights
BioSpace
Tue, 01/10/23 - 06:50 pm
Tags:
JPMHC 2023, Relay Therapeutics, Sanofi, Scholar Rock, SAGE Therapeutics, Karuna Therapeutics, GSK
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool
Sun, 01/8/23 - 10:13 pm
Tags:
Sanofi, Dupixent
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
Tags:
RSV, Sanofi, AstraZeneca, FDA, antibodies, nirsevimab
Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says
Fierce Biotech
Thu, 01/5/23 - 10:09 am
Tags:
clinical trials, clinical trial diversity, oncology, Sanofi, United Therapeutics, Bristol Myers Squibb
Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year
Endpoints
Wed, 01/4/23 - 05:16 pm
Tags:
Sanofi, Boehringer Ingelheim, Zantac, legal
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Tags:
Amgen, Sanofi, Regeneron, Supreme Court, legal, innovation, patents, Repatha, Praluent
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
Tags:
clinical trials, Alzheimer's disease, obesity, Huntington's disease, M&A, AstraZeneca, Daiichi Sankyo, Nimbus Therapeutics, Takeda, Eli Lilly, Sanofi, Regeneron, Moderna Therapeutics, Gilead Sciences, Pfizer, Roivant, Alnylam, uniQure
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Tags:
Eli Lilly, Rezvoglar, diabetes, Sanofi, Lantus, biosimilars, long-acting insulin
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
Fierce Biotech
Mon, 12/19/22 - 11:19 am
Tags:
Sanofi, Innate Pharma, natural killer cells, solid tumors
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Tags:
Kymera Therapeutics, Sanofi, protein degradation, hidradenitis suppurativa, atopic dermatitis, KT-474
Sanofi sets Revolution back, sending $550M SHP2 inhibitor deal to the docks
Fierce Biotech
Fri, 12/9/22 - 10:26 am
Tags:
Sanofi, Revolution Medicines, SHP2 inhibitors, RMC-4630
GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing
Fierce Pharma
Tue, 12/6/22 - 08:54 pm
Tags:
GSK, Sanofi, Takeda, Singapore, biologics
Janssen Bows Out as Contender for Horizon Therapeutics Buyout
BioSpace
Mon, 12/5/22 - 10:59 am
Tags:
Horizon Therapeutics, M&A, Agmen, Sanofi, Janssen, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.